← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 26, 2013Last known activity
Nov 10, 2017
Timeline
2000s
- Jun 1, 2002
Galeno Desenvolvimento de Pesquisas— Founded
Drugs by trial phase (19 distinct, 16 trials)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (30)
- NCT03343912Lead sponsorPhase 1Nov 10, 2017
- NCT03343912Reponsible party - principal investigatorPhase 1Nov 10, 2017
- NCT03343912Overall official - principal investigatorPhase 1Nov 10, 2017
- NCT03320486Overall official - principal investigatorPhase 3Nov 1, 2017
- NCT02667535Overall official - principal investigatorPhase 1Jul 1, 2017
- NCT02667561Overall official - principal investigatorPhase 1Jul 1, 2017
- NCT03443089Reponsible party - principal investigatorPhase 1Mar 31, 2017
- NCT03443089Overall official - principal investigatorPhase 1Mar 31, 2017
- NCT03443089Lead sponsorPhase 1Mar 31, 2017
- NCT03363997Lead sponsorPhase 1Sep 23, 2016
- NCT03363997Overall official - principal investigatorPhase 1Sep 23, 2016
- NCT03363997Reponsible party - principal investigatorPhase 1Sep 23, 2016
- NCT02606383Overall official - principal investigatorPhase 3Jun 1, 2016
- NCT02607696Overall official - principal investigatorPhase 1May 1, 2016
- NCT02607657Overall official - principal investigatorPhase 1May 1, 2016
Details
- Founded
- Sao Paulo, BR Jun 1, 2002
- Last known activity
- Nov 10, 2017